目的:已提出姿势矫正带(PCBs)作为辅助手段来帮助胸部扩张和增强呼吸功能。然而,多氯联苯对在家中进行吸气肌训练(IMT)的社区老年人的影响尚不清楚.
方法:将65岁及以上的社区人群分为PCB组,穿着多氯联苯,和NPCB集团,不戴PCB。IMT方案持续8周,每周5次,包括每天4套,每套重复15次。训练强度设定为每个受试者的最大吸气压力的50%。为了评估IMT的影响,呼吸功能,6分钟步行测试,之前测量了握力,during,在训练期之后。使用重复测量方差分析对数据进行分析,事后评估采用Bonferroni校正。
结果:共40名受试者均分为PCB组和NPCB组,每组20名受试者。根据PCB的使用,呼吸肌强度没有显着差异。然而,在最初的4周内,与NPCB组相比,PCB组表现出呼吸肌力量增加的趋势;这种趋势,然而,到8周结束时,没有证明具有统计学意义。两组在6分钟步行测试中的表现均显着改善。
结论:PCB组在前4周表现出呼吸肌力增加的趋势;然而,最终与NPCB组相比无显着差异。
背景:这项研究已在临床研究信息服务处注册,世界卫生组织国际临床试验注册平台的一部分(临床研究信息服务编号:KCT0008075)。
OBJECTIVE: Posture correction bands (PCBs) have been proposed as aids to help chest expansion and to enhance respiratory function. However, the impact of PCBs on community-based older individuals engaged in inspiratory muscle training (IMT) at home remains unclear.
METHODS: Community-based individuals aged 65 years and older were divided into the PCB group, wearing PCBs, and the NPCB group, not wearing PCBs. The IMT regimen lasted 8 weeks, with sessions 5 times a week, including 4 sets per day and 15 repetitions per set. Training intensity was set at 50% of the maximum inspiratory pressure of each subject. To assess the effects of IMT, respiratory function, 6-minute walk test, and grip strength were measured before, during, and after the training period. Data were analyzed using repeated-measures analysis of variance, with post-hoc evaluation employing Bonferroni correction.
RESULTS: A total of 40 subjects were evenly divided into the PCB group and the NPCB group, with 20 subjects in each group. No significant difference was observed in respiratory muscle strength based on PCB use. However, during the initial 4 weeks, the PCB group exhibited a trend towards an increase in respiratory muscle strength compared to the NPCB group; this trend, however, did not prove to be statistically significant by the end of the 8-week period. Performance on the 6-minute walk test significantly improved in both groups.
CONCLUSIONS: The PCB group exhibited a tendency for increase in respiratory muscle strength in the first 4 weeks; however, ultimately there was no significant difference compared to the NPCB group.
BACKGROUND: This study was registered with the Clinical Research Information Service, part of the World Health Organization\'s International Clinical Trials Registry Platform (Clinical Research Information Service No. KCT0008075).